CASI Pharmaceuticals, Inc(NASDAQ:CASI) 
CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in China, the United States, and internationally. The company offers EVOMELA, an intravenous formulation of melphalan for use as a conditioning treatment prior to stem cell t...
Website: http://www.casipharmaceuticals.com
Founded: 1991
Full Time Employees: 125
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 2.06
H 2.22
L 2.04
C 2.09
V 11,130
10EMA 2.09
20EMA 2.09
60EMA 2.09
120EMA 2.09
250EMA 2.09